Abstract. Interferons, in addition to their antiviral activity, induce a multiplicity of effects on different cell types. Interferon (IFN)-3, exerts a unique regulatory effect on cells of the mononuclear phagocyte lineage. To investigate whether the antiviral and antiproliferative effects of IFN-~ in macrophages can be geneticaUy dissociated, and whether IFN-ot and IFN-3, use the same cellular signals and/or effector mechanisms to achieve their biologic effects, we have derived a series of somatic cell genetic variants resistant to the antiproliferative and/or antiviral activities of IFN-3,. Two different classes of variants were found: those resistant to the antiproliferative and antiviral effects of IFN-'t against vesicular stomatitis virus (VSV) and those resistant to the antiproliferative effect, but protected against VSV and encephalomyocarditis virus (EMCV) lysis by IFN-~. In addition, a third class of mutants was obtained that was susceptible to the growth inhibitory activity, but resistant to the antiviral activity of IFN-7. Analysis of these mutants has provided several insights regarding the regulatory mechanisms of IFN-3, and IFN-o~ on the murin¢ macrophage cell lines. The antiproliferative activity of IFN-3, on these cells, in contrast to that of IFN-ot, is mediated by a cAMP-independent pathway. The antiproliferative and antiviral activities of IFN-3, were genetically dissociated. Variants were obtained that are growth resistant but antivirally protected, or are growth inhibited but not antivirally protected against VSV or EMCV. The genetic analysis indicated that IFN-~ and IFN--y regulate the induction of the dsRNA-dependent P1/eIF2a protein kinase and 2',5'-oligoadenylate synthetase enzymatic activities via different pathways. Finally, a unique macrophage mutant was obtained that was protected by IFN-'y against infection by VSV, but not EMCV, suggesting that antiviral mechanisms involved in protection against these different types of RNA viruses must be distinct at some level.
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I
NTERFERONS (IFNs) ~ are defined as molecules that induce an antiviral state, but in addition are known to exert a multiplicity of effects on a variety of different cell types, including the inhibition of cell proliferation 07, 24, 35, 47) . Of the three classes of IFN known, IFN-a and IFN-/3 share a common cell receptor while IFN-7 binds to a distinct cell receptor (5) . Two unique interferon-induced enzyme activities have been implicated in the antiviral effects of IFN-ot and IFN-/3, namely, the P1/eukaryotic initiation factor-2ot (P1/eIF-2ot) protein kinase and 2',5 '-oligoadenylate synthetase (2',5'-(A)n synthetase) systems (reviewed in 28, 36) , but it is unknown whether similar mechanisms are used by IFN-'y. While IFN-ot and IFN--y elicit common cellular responses in many cell types, IFN-), has specific effects on cells of the mononuclear phagocyte lineage. IFN-'r can increase Fc receptor-mediated phagocytosis (38) , induce the expression of major histocompatibility L Abbreviations used in this paper: elF-2, eukaryotic initiation factor-2; EMCV, encephaiomyocarditis virus; G i, growth inhibited; G r, growth resistant; IFN, interferon; 2',5'-(A)n, 2',5'-oligoadenylate; VP, antivirally protected; V s, susceptible to viral lysis. complex class I and class II antigens (23, 46) , and activate macrophages to produce a respiratory burst after endocytosis of bacteria or parasites (34) . Electrophoretic analysis of polypeptides derived from IFN-,y-treated human fibroblast lines revealed that at least 12 unique proteins are induced by IFN-~/(50). The molecular mechanisms of the antiproliferative and antiviral effects of interferon, or the unique activation of macrophages by IFN-'t remain largely unknown.
One approach to understanding the mechanisms by which IFNs, and in particular IFN-% act to regulate mononuclear phagocyte function is a somatic cell genetic analysis using cloned macrophage cell lines. In previous studies we observed that macrophage variants in cAMP metabolism of the J774.2 murine macrophage cell line were 50-fold less sensitive to the antiproliferative effects of IFN-ot than the parental clone (43). Conversely, a role for cAMP was confirmed by selecting for IFN-ot-resistant mutants, five of which were shown to have defective adenylate cyclase, providing genetic evidence that IFN-ot uses a cAMP-dependent signal transduction mechanism in mediating the antiproliferative effects in at least one type of cell (33) . The antiviral state was fully induced by IFN-u in the adenylate cyclase mutants, thus demonstrating that it was possible genetically to dissociate the antiviral and antiproliferative effects of IFN-o~.
Because IFN-'y is known to have unique effects in regulating macrophage function, as well as inducing the antiviral and antiproliferative effects on macrophage cell lines, we have attempted here to investigate two questions: (a) whether one can genetically dissociate the antiviral and antiproliferative effects oflFN-3,, as in the case of IFN-t~; and (b) whether IFN-ot and IFN-~/use the same cellular signals and/or effector mechanisms to achieve these biological effects.
Materials and Methods

Cells
The cloned cell line, J774.2, was originally established from a mouse reticulum cell sarcoma derived by P. Ralph et al. (39) and shown to have a macrophage-like phenotype (4, 32) . J774.2 and variant clones were maintained in DME, supplemented with 20% heat-inactivated horse serum, 0.1 mM nonessential amino acids (NEAA), 10% NCTC 109 conditioned media (Microbiological Associates, Walkersviile, MD), penicillin, and streptomycin at 37°C in a humid incubator containing 7% CO2.
The mouse bepatoma cell line, E3, was grown in DME supplemented with 10% heat-inactivated FCS, 5% NCTC 109, and 1% NEAA. Primary rat embryo fibroblasts were cultured in DME supplemented with 10 % FCS. DME, horse and fetal calf serum, NEAA, penicillin, and streptomycin were from Gibco Laboratories, Grand Island, NY.
Viruses
The Indiana serotype of vesicular stomatitis virus (VSV) was prepared in chicken embryo fibroblasts, clarified by centrifugation (1,000 g, 10 min), and had a titer of 3.0 × l0 s pfu/ml. The stock was divided into small portions, frozen at -70°C, and diluted into regular macrophage cell culture medium before use. Encephalomyocarditis virus (EMCV) was obtained from J. Paucker (University of Pennsylvania, Philadelphia, PA) and had a titer of 5 x 107 pfu/mi.
Interferon
Recombinant Escherichia coil-derived murine IFN-'y (Genentech Inc., San Francisco, CA) had a specific activity of 1.24 x 107 U/rag. Murine IFN-cx was obtained from Lee Biomolecular Company (catalogue No. 22061; San Diego, CA) and had a specific activity of 2.7 × 106 U/mg. Interferon activity was assayed by the inhbition of cytopathic effects of EMCV on L cells in microtiter wells. Interferon activity was routinely titered once a month to determine if any loss of activity had occurred.
Cloning of Macrophage Lines
Macrophage cell lines and variants were cloned in Sea plaque ngarose (FMC Corporation, Rockland, ME) on a rat embryo fibroblast or E3 feeder layer. A 1:20 dilution of a confluent layer of feeder cells was plated 18 h before cloning in a 60-ram tissue culture dish (Falcon Labware, Oxnard, CA). 16 h later the medium was aspirated off and 4 ml of medium plus agarose (final concentration 0.45% [wt/vol]) was allowed to solidify at 4°C for 10 rain. Macrophage cell suspension was diluted 1:10 with medium plus agarose and I ml of cell suspension was layered on top of the solidified agarose. After 10 min at 4"C the cells were placed in a 37"C incubator at 7% CO2. Macrophage colonies were picked 7-9 d later.
Selection of lFN-resistant Variants
J774.2 cells were cloned in 4,000 U/ml of IFN-3' without prior mutagenesis. The clones were then grown in increasing concentrations of IFN-3' from 500 to 4,000 U/ml over a 3-4-wk period. Clones able to grow in the presence of 4,000 U/ml of IFN-,'/were allowed to grow in cell culture in IFN-'r-free medium for a month and were then retested for their ability to grow in IFN-3,. A spontaneous mutant was derived from J774.2 cells which were maintained in culture for 1.5 yr, that was growth inhibited by IFN-3,, although susceptible to viral iysis 0774.2-7 = GINS). After the discovery that the culture was not as responsive vis-/t-vis the antiviral activity of IFN-% the cells were subcloned for isolated colonies and retested for their phenotype.
Growth Curves
Cells in log phase were seeded (7.5 x 103 cells/0.15 ml) in 96-well plates (Linbro, Flow Laboratories, Hamden, CT), in the absence or presence of the various IFNs and cholera toxin. At the time intervals indicated 0.025 mi of tritiated thymidine at 0.04 mCi/ml was added per well (final concentration of l/~Ci/well). After a 45-min incubation 0.05 ml of 0.45% NP40 in PBS was added per well for 5-10 min with moderate rotation on an orbital gyrator. Nuclei were harvested onto glass filter paper, dried, and counted with liquiscint for 1 min on a liquid scintillation counter. Results for each experimental point is the average of triplicate wells. Individual wells did not differ generally >1 SD from the mean. Preliminary experiments showed that the inhibition of thymidine incorporation by IFN-ct and IFN-v paralleled the actual growth inhibition as measured by counting the number of viable cells excluding trypan blue with a hemocytometer.
Viral Infection
Cells (2-4 x 105) were plated in 2-cm 2 wells (Linbro) for 21 h in 1 ml of medium in the presence and absence of IFN. VSV or EMCV, at a multiplicity of infection of 0.1, was added and the cells cultured for an additional 18-24 h. Supernatants were collected and stored frozen at -700C.
Viral Yield
Serial 10-fold dilutions (0.2 ml) of the above supernatant fluids were added to confluent Veto cell monolayers in 2-cm 2 wells. After 1-h adsorption at 37°C, 1 ml of warm medium containing 0.75% carboxyi methyl cellulose was added, and wells were incubated for an additional 36-48 h. The monolayers were then fixed for 10 min, stained with crystal violet, and viral plaques counted.
RNA Isolation
For the preparation of cytoplasmic RNA, cells were harvested, either by pipetting or scraping them off the dish, then washed twice with cold PBS, and resuspended in 0.45 ml of ice-cold buffer containing 10 mM Tris HCI, 1 mm EDTA, and 10 mM vanadyl nucleoside. Cells were lysed by adding 0.05 rni of 5% NP-40 (final concentration 0.5%), incubated 5 min on ice, and then another 0.05 ml was added for an additional 5 min. The nuclei were centrifuged at 1,500 rpm for 5 rain and the superuatant was transferred into another tube. 2 vol of SDS buffer containing 200 mM Tris pH 9.0, 50 mM sodium chloride, 10 mM EDTA, and 0.5% SDS was added to a single volume of superoatant. The supematant was deproteinized with phenol twice and then with chloroform isoamylalcohol. 0.1 vol of 3 M sodium acetate pH 5.2 and 2.5 vol of 95% ethanol was added and the RNA was precipitated overnight at -20°C.
RNA Analysis
RNA was analyzed by Northern blot analysis (14) . The human 2',SL(A), synthetase gene probe (clone 6-2) (42), was subcloned into pGEM for the production of riboprobes. Biodyne nylon blots were hybridized with T7 riboprobes. Cytoplasmic RNA was blotted onto Biodyne filters and prehybridized for 4 b at 590C under the following conditions: 50% formamide, 6x SSC, 1% SDS, 0.1% Twcen 20, 100 ~tg/ml tRNA, and 10 mM DTT. Labeled RNA (106 cpm/ml) was added to the hybridization solution for an additional 18 h. The filters were washed once with 2x SSC and 0.1% SDS for 30 min at room temperature, then with 2x SSC and 0.1% SDS at 65°C, and finally 0.2x SSC and 0.1% SDS at 650C for 30 min.
Gel Electrophoresis
SDS (0.1%)-10% PAGE was performed according to Laemmli (27) . Gels were run with molecular mess merkers as follows: lysozyme (Mr = 14,300), ~-Iactoglobulin (Mr = 18,400), ot-chymotrypsinogen (Mr = 25,700), albumin (Mr = 43,000), bovine serum albumin (Mr --58000), phosphorylase B (Mr = 97,400), and myosin (H chain) (Mr --200D00). For analysis of proteins labeled with [35S]methionine, the gel was impregnated with En3Hance, dried, and subjected to autoradiography at -70°C. incorporated from triplicate wells.
Cell extracts were applied to polyI:polyC agarose columns (P. L. Biochemicals, Inc., Milwaukee, WI) and then equilibrated with 25 ml of 20 mM Hepes pH 7.5, 90 mM KCi, 8.5 mM magnesium acetate, 7 mM betamercaptoethanol, and 20% glycerol. The agamse column was then washed three times with 100/~1 of cold reaction mixture containing the same buffer and 3 mM ATE 0.2% creatine phosphate, 0.03% creatine phosphokinase, followed by the same mixture containing purified 3H-ATP. The column was incubated at 30"C for 15 h and then the supernatant was boiled for 3 min to destroy any nucleases. The 2',5'-(A), was separated from the unconverted ATP and DEAE columns by elution with 350 mM KCI at pH 7.5.
Assay of Double-stranded RNA-dependent PllelF-2a Protein Kinase Activity
Cells were cultured for 21 h with or without IFN-7 (500 IU/ml) and then detergent extracts of cells were prepared as previously described (20) . The reaction volume for the P1/eIF-2c~ protein kinase assay was 0.05 nd and contained 100 mM KCI, 5.0 mM beta-mercaploethanol, 10.0 mM magnesium chloride, 1 mm 32p-T-ATP at 104 cpm/pmol, 2 ~g/ml of double-stranded RNA (polyI:polyC), and 100 t~g protein from cell extracts. Incubations were performed at 30°C for 30 rain and phosphorylated proteins were analyzed by gel electrophoresis.
Results
Description of lFN Variants
The initial question we wished to address was whether the antiviral and antiproliferative effects of IFN--y could be genetically dissociated, or were mediated by a common mechanism. IFN-7 exerts a powerful antiproliferative effect on the growth of ceUs of the J774.2 macropbage cell line (Fig. 1 A) . Our approach to the question was to select variants of J774.2 genetically resistant to the antiproliferative effects of IFN-3, by cloning the cells in 4,000 IU/ml of IFN-v without prior mutagenesis. The clones obtained were tested for their sensitivity to IFN-7 after growing 1 mo in IFN-7-free medium, and five clones resistant to the antiproliferative effects of IFN-'t were isolated in two independent cloning experiments. The growth characteristics of some of these variants are illustrated in Fig. 2 . Variants resistant to growth inhibition by IFN-y were then analyzed for the induction of an antiviral state by IFN-'y as determined by reduction in yields of VSV (Table I) . Two different classes of variants were found, based on their sensitivity to lysis by VSV after IFN-~, treatment: growth resistant to IFN--y/protected against VSV lysis (Gr/Vp); and growth resistant to IFN-~,/susceptible to VSV lysis after IFN-3, treatment (G'/Vs). G'/Vp variants, represented by J7-/R1, J7-yRS, and J7"yR10 were protected against VSV infection. Gr/V s variants, represented by J7~R5 and J73,R7 were susceptible to VSV lysis. Of particular interest, one clone, J73,R5, that was susceptible to VSV was consistently protected by IFN-3, against the EMCV infection, and thus must have a functional IFN-3, receptor (Table II). A third class of variants, represented by a spontaneous mutant of J774.2 which arose after the cells were maintained for 1. ( Table II) . The existence of mutants of these diverse phenotypes provides firm genetic evidence that the antiviral and antiproliferative effects of IFN--~ can be dissociated (summarized in Table III) . Thus, there must be a divergence of the intracellular responses to IFN-'t beyond the receptor level allowing the antiviral and antiproliferative effects to be independently regulated within the cells.
Mechanism of Inhibition of Viral Replication by IFN-~
The molecular mechanisms responsible for the antiviral effects of IFNs are not fully understood in any system, least of all for IFN--y. With the possibility that our somatic cell mutants could provide insight into this important issue, the mutants defective in their antiviral response to IFN-q¢ were analyzed for the two known biochemical markers previously implicated in the antiviral actions of IFN-c~ and -13. A Viral yields were determined as described in Table I , in response to IFN-3" (1,000 IU/ml) and IFN-t~ (500 IU/ml). Growth inhibitory effects of IFN-3' were derived from data in Figs. 1 and 2 . Data for reduction of VSV yields were derived from Tables I and II. P1/elF-2u protein kinase, in the presence of dsRNA, autophosphorylates itself and subsequently eukaryotic initiation factor-2, preventing the recycling of elF-2o~ which thereby inhibits polypeptide chain initiation. In contrast to the significant P1/elF-2ct protein kinase activity induced by IFN-3, in the parental J774.2 line, the Gi/V s variant exhibited no demonstrable P1/elF-2ot protein kinase activity, and the Gr/V s variant showed a diminished, but reproducible level of activity (Fig. 3) . The GqVp (growth resistant, but antivirally protected by IFN--y) cell line had similar P1/elF-2t~ kinase activity as the parental line, indicating that long-term growth of these cells in IFN-3, does not nonspecifically depress enzyme activity (Fig. 4) . Two explanations for the lack, or decrease, in the G~/V s and GqV' variants, respectively, of P1/elF-2ct protein kinase activity, were considered. One possibility is that the mutant selected is a variant containing a defective P1/elF-2a protein kinase. Alternatively, it is possible that only the regulation of the kinase by IFN-3, is defective, the enzyme itself being fully functional. To distinguish between these two possibilities, we examined whether IFN-a could induce the antiviral state in these sets of variants. Since the same variants, summarized in Table II , were protected against VSV and EMCV infection by IFN-ct, it was possible critically to test whether the Gi/V s and GqV s variants were capable of producing a functional dsRNA-dependent P1/elF-2ot protein kinase in response to IFN-a. The results indicated that the G~/V ~ and Gr/V s variants had an equal or greater amount of P1/elF-2t~ protein kinase activity after IFN-ct treatment as compared the parental clone (Figs. 5 and 6), indicating that the lack of antiviral activity in response to IFN-q/is most likely due to a defect in its regulation by IFN-% The second biochemical mechanism associated with antiviral activity is the induction of the dsRNA-dependent 2'5'-(A), synthetase activity by the IFNs. This enzyme, in the presence of dsRNA, converts ATP into a 2',5'-(A)o that activates a latent endonuclease capable of degrading viral RNA. The spectrum of results in our variants followed a pattern very similar to that obtained in P1/elF-2a protein kinase activity. While the parental line showed a 22-fold induction of 2',5'-(A)n synthetase activity in response to IFN-3, treatment, the G~/V s variant lacked any detectable 2',5'-(A)n synthetase activity above background levels, while the GqV s variant had an approximately twofold higher basal level of 2',5'-(A)n synthetase activity and a twofold increase above this level after IFN-3~ treatment (Table IV) . The Gr/V p variant had a similar increase in 2',5'-(A)n synthetase activity in response to IFN-q~ as the parental line. Interestingly, this variant had a fourfold higher basal level of 2',5'-(A), synthe- tase activity as compared with the parental line. Again, to differentiate whether the Gi/V ~ and Gr/V s variants contained a structural defect in the 2',5'-(A). synthetase or was defective in their regulation by IFN--y, the induction of 2',5'-(A)n synthetase activity after IFN-c~ treatment was measured. The 2',5'-(A)o synthetase activity induced by IFN-a in these variants was fully comparable to that of the parental cell line, indicating again that there is a defect in the regulation of this enzyme by IFN-3, (Table IV) . The results derived from the G~/V ~ variant implicate for the first time a common regulatory pathway inducing both the 2',5'-(A). synthetase and P1/dF-2o~ protein kinase activities by IFN-ff, which must be distinct from both the pathway involved in regulating the antiproliferative effects mediated by IFN-3,, as well as the pathway involved in the antiviral response mediated by IFN-ot. These results are consistent with the possibility that IFN--~ and IFN-ot may use the same effector mechanisms to induce the antiviral state in J774.2 cells, and that only the regulation of these enzymes by IFNs differs.
To further delineate the nature of the defects in the G~/V ~ and Gr/V ~ variants, induction of 2',5'-(A), synthetase mRNA levels in response to the IFNs were measured. Northern blot analysis after induction with IFN-3, for 8 h revealed that the 2',5,'-(A)n synthetase mRNA levels in the Gr/V s variant was comparable to the parental clone (Fig. 7) . Interestingly, IFN-~/did not induce 2',5'-(A)n synthetase mRNA levels in the GitV s variant. Thus, the nature of the defects in the Gi/V s and Gr/V s variants are different, involving possibly transcriptional and posttranscriptional processes, respectively.
Mechanisms of AnU'proliferative Effects of lFN-7 and IFN-ol
If IFN-7 and I F N -. mediate their antiproliferative effects via different pathways, one might expect to find significant differences in their kinetics of action and dose-response curves. Therefore, we compared the sensitivity of J774.2 cells to the antiproliferative and antiviral effects of both IFN-3, and IFN-ot. The antiproliferative and antiviral effects of IFN-cx were dose dependent, but 100-1,000-fold greater amounts were required to inhibit cell growth than to engender the antiviral state (Fig. 1) . In contrast, the concentration of IFN--/ required maximally to induce cells for the antiviral state was sufficient completely to arrest growth of the cells. Further, a kinetic difference exists between the two IFNs, in that IFNq~-mediated effects appear only after 18-20 h, allowing the cells to divide at least once, whereas IFN-ot can prevent the cells from dividing. These data are most consistent with the interpretation that the antiproliferative effects of IFN-o~ and IFN--y are mediated by separate pathways.
A more rigorous genetic approach was undertaken to explore this question. We have previously reported that the an- 
Discussion
Three different classes of variants in the J774.2 macrophage cell line defective in their responses to IFN-3, have been derived from these studies (summarized in Table V) . From a careful analysis of their phenotypes, we believe that several inferences regarding the regulatory mechanisms by which interferons act on these cells can be drawn. By way of commentary, it is not suprising that the seemingly similar antiproliferative response to IFN-a and IFN-~/ in the same cloned cell line could be mediated via different regulatory signals. A wide variety of growth factors, hormones, lymphokines, and differentiation-inducing factors are known to act on the same structural gene by regulatory pathways involving different second messengers and transacting factors. For example, metaUothionein genes are regulated by such diverse agents as the glucocorticoids, zinc and cadmium ions, cAMP, TPA, and IFN-a, through distinct tiproliferative effects of IFN-ot on the J774.2 cell line was cAMP dependent (32, 39) . To test whether the same was true for the IFN-3, antiproliferative effects, cholera toxin-resistant clones were tested for their sensitivity to IFN-3,-mediated growth inhibition. Cholera toxin-resistant clones have been previously shown to be defective in adenylate cyclase, and were found here to be fully sensitive to the antiproliferative effects of IFN-3, (Fig. 8 B) . Furthermore, all the IFN-'t growth-resistant variants remain fully susceptible to growth inhibition by cholera toxin (Fig. 8 A) , These results provide formal genetic evidence that the antiproliferative response of J774.2 induced by IFN-3~ is cAMP independent. Finally, we examined whether the IFN--y growth-resistant variants were sensitive or resistant to IFN-ot-mediated antiproliferative effects. All of the IFN-~ growth-resistant mutants were fully sensitive to the antiproliferative effects of IFN-ot (Fig. 2) . These results provide genetic evidence that IFN-3, and IFN-a elicit antiproliferative responses in the J774.2 cell line through different signaling pathways. regulatory sequences in the 5' region of the gene (reviewed in 21). The proenkephaiin gene has been shown to be transcriptionally activated by both the adenylate cyclase pathway via cAMP, as well as the phosphatidylinositol pathway via protein kinase C (11). Interestingly, the DNA sequences required for the regulatory effects for both cAMP and phorbol esters mapped to the same 37-bp 5' region of the human enkephalin gene. In bone marrow-derived macrophages, CSF-1 has been reported transiently to induce c-fos mRNA levels via phospholipid degradation, protein kinase C activation, and Ca z+ mobilization (6) . Of particular interest, because of our previous finding that IFN-ot exerts its antiproliferative effects in J774.2 macrophage cell lines via intracellular cAMP, it was similarly shown that dibutyryl cAMP or cholera toxin could lead to the stable induction of c-fos transcription in these same bone marrow macrophages. In this regard, we have preliminary genetic evidence indicating that the antiproliferative response of mouse macrophages to IFN-,y is mediated through a protein kinase C-dependent pathway (Goldberg, M., L. S. Belkowski, and B. R. Bloom, manuscript submitted for publication). It will be fundamentally important to establish whether IFN-3, and IFN-ot are using different signals to exert regulatory effects on the same effector genes that mediate the antiproliferative effects, e.g., transcriptionally inactivating the same proto-oncogenes, or whether IFN-a and IFN-3, affect the expression of distinct genes that lead to a common growth inhibitory effect. The second question addressed in this work concerns whether different pathways were responsible for mediating the different biological responses to IFN-~ in the mouse macrophage cell line. We had previously derived variants that were resistant to the antiproliferative effects of IFN-c~, and found them to be fully protected against lysis by VSV (33). In similar experiments, we have been able genetically to dissociate the antiviral and antiproliferative effects of IFN--y by isolating variants specifically unresponsive to one, but not the other of these effects. Our results suggest for the first time the possibility that a common molecule regulates both the P1/eIF-2a protein kinase and the 2',5'-(A). synthetase activities that must be distinct from molecules involved in regulating the antiproliferative responses to IFN-% The G~/V s variant fails to show induction of both of these enzymatic activities after treatment with IFN-% even though the enzymes themselves are fully functional, as indicated from the induction of their activity by IFN-o~. At what point does the bifurcation of the cellular responses to IFNs occur? The available evidence indicates the existence of a single biologically functional high affinity receptor for IFN-~ on many eel] types including macrophages (1, 8) , with which our preliminary Scatchard data on J774.2 are consistent. The receptor molecule itself could conceivably mediate different effects by binding to regulatory regions of different genes, as is the case for the glucocorticoid receptor (2); or, the different biologic effects could diverge subsequent to binding and triggering of the receptor, for example, by generating transducing factors that regula R different genes in different ways. Evidence on a human macrophage cell line, U937 cells;:indicates clearly that transcriptional activation of IFN-7-inducible genes can occur by at least two separate pathways, protein kinase C dependent and independent (14) . Further, cycloheximide can block the transcriptional induction of only a subset of IFN-o~ and IFN-~-induced genes implicating multiple pathways by which the IFNs exert their regulatory control (7, 13, 16, 29) . From several studies on gene regulation by I F N -, and IFN-/~, transcriptional regulatory regions of IFN-inducible genes appear to be necessary, but not fully sufficient for the regulatory effects induced by the IFNs. For example, IFN-otinducible genes contain homologies in their 5' flanking regulatory regions (10, 15, 37, 40, 41) , although the cytoplasmic mRNA levels for some of these genes is determined by posttranscriptional mechanisms (16, 25) Our attempts to clarify the molecular mechanisms responsible for the antiviral effects of the two classes oflFN in these experiments presented an unexpected finding regarding the specificity of antiviral mechanisms for different RNA viruses. It has long been known that there are differences in both kinetics and mode of action in the induction of the antiviral state by IFN-~ and IFN-cc IFN-ct generally requires a shorter time to induce the antiviral state than IFN-% the thought being that IFN-~, requires more than one round of protein synthesis to induce the antiviral state (3, 12) . The Mx gene product involved in natural resistance to influenza infection in mice is specifically induced by IFN-ct, but not IFN-), (45) . On the other hand, it appears that adenoviruses can be inhibited by IFN-7, but not IFN-ct (30). While we have no formal proof that the antiviral effects of IFN-3, are mediated through dsRNA-dependent P1/elF-o~ protein kinase or 2',5'-(A)n synthetase, our results are consistent with the interpretation that either or both of those pathways may be involved in resistance to VSV and EMC replication, although our data would suggest that IFN-c~ and IFN-~, must utilize different pathways to regulate these genes.
Throughout the interferon literature, correlations between the antiviral state and enzymatic activities of 2',5'-(A), synthetase and P1/elF-2o~ protein kinase induced by IFNs represent a major theme. For example, the role of the P1/elF-2a protein kinase system in the antiviral response has been strengthened from the analysis of adenoviruses and vaccinia viruses that have devised strategies to overcome the activity of the P1/elF-2ct protein kinase system (22, 44, 51, 52) . Strong support for a role of the 2',5'-(A), synthetase derives from transfection studies in Chinese hamster ovary (CHO) cells. High constitutive expression of the 2',5'-(A), synthetase correlated to resistance to infection by a picornavirus such as mengo, but not to the rhabdovirus, VSV (9) . Consistent with this general view, the J774.2-7 variant, which is fully growth inhibited by IFN-3,, exhibited no demonstrable P1/elF-2ot protein kinase activity or 2',5'-(A), synthetase activity after IFN-3/treatment, and was not protected against VSV or EMCV. Our genetic evidence is corroborated by biochemical data that shows IFN-7 completely inhibits VSV protein synthesis in the J774.2 cell line (data not shown). This finding contrasts to a report that implicates primarily a posttranslational step in the IFN-3~-induced antiviral activ- ity in a human amniotic cell line (48, 49) , raising the unhappy possibility that the antiviral effects of IFNs may be mediated by distinct molecular mechanisms in different cell types.
Another mutant defective in the IFN--/-mediated antiviral response presents a unique phenotype. This variant, J7~,R5, is resistant to the antiproliferative effects of IFN--y and is protected against viral lysis caused by EMC virus, but not by VSV. This variant exhibits a small, but consistently detectable level of P1/elF-2ot protein kinase activity and 2',5'-(A), synthetase activity induced by IFN-% A similar variant has been described in a human rhabdomyosarcoma cell line which is protected by human IFN-7 against EMCV, but not VSV (26) . Constituitive expression of the cDNA encoding the 40-kD 2',5'-(A), synthetase recombinant protein in CHO cells resulted in reconstitution of resistance against a related picornavirus, mengo virus, but not VSV (9) . The mechanism for this differential sensitivity of EMCV and mengo virus relative to VSV is unclear, although qualitative differences in mechanisms of replication of positive stranded viruses, such as EMC or mengo, relative to a negative-stranded virus, like VSV, may be important. Alternatively, the mutation that allowed this variant to grow in the presence of IFN-3, may also permit the transcriptional activation of the VSV genome, but not of the EMCV genome. Indeed, there is evidence that tubulin and microtubular-associated proteins can stimulate VSV transcription in vitro (19, 31) . Curiously the J7qcR5 variant, unlike the parental line, falls to undergo any morphologic changes in the presence of IFN-% and only poorly adheres to surfaces after treatment with IFN-3,.
Finally, we hope that the macrophage variants described, in addition to facilitating analysis of differential signalling pathways and possible effector mechanisms involved in cellular responses to IFNs, may provide unique possibilities for isolating genes encoding important effector proteins and trans-acting regulatory factors involved in interferon action.
